Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Drug Safety Institute (DSI) is a wholly-owned regulatory subsidiary of Brand Institute that provides guidance on drug name safety, packaging, and labeling to help prevent medication errors. It delivers global regulatory expertise, strategy, and name development research for brand names and nonproprietary names (USAN/INN), drawing on leaders from FDA, EMA, Health Canada, AMA, and WHO. DSI currently partners on over 75% of new pharmaceutical brand and nonproprietary name approvals worldwide each year.
Parse Score